Back to Search
JAMES INGLE, M.D.
M.D.
Medical Oncology Physician
NPI: 1356327670Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
22613(MN)
Research & Publications (20)
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
PMID 18072254·Cancer·2008
8-other
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
PMID 18332043·Ann Oncol·2008
2-rct
Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer.
PMID 19128430·Breast Cancer Res·2008
8-other
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
PMID 16538529·Breast Cancer Res Treat·2006
2-rct
Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
PMID 16505423·J Clin Oncol·2006
3-trial
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.
PMID 16541302·Breast Cancer Res Treat·2006
4-observational
Adjuvant endocrine therapy for postmenopausal women with early breast cancer.
PMID 16467121·Clin Cancer Res·2006
1-meta
Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings.
PMID 15701884·Clin Cancer Res·2005
6-review
Aromatase inhibitors for therapy of advanced breast cancer.
PMID 15939585·J Steroid Biochem Mol Biol·2005
4-observational
Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer.
PMID 14734492·Clin Cancer Res·2004
8-other
Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings.
PMID 14623527·J Steroid Biochem Mol Biol·2003
4-observational
Adjuvant endocrine therapy in postmenopausal breast cancer.
PMID 12538504·Clin Cancer Res·2003
6-review
Current status of adjuvant endocrine therapy for breast cancer.
PMID 11916230·Clin Cancer Res·2001
6-review
Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention.
PMID 11396362·Oncology (Williston Park)·2001
6-review
Multicultural aspects of breast cancer etiology workshop: concluding comments.
PMID 10705365·Cancer·2000
8-other
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
PMID 19621224·Cancer Immunol Immunother·2010
8-other
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging.
PMID 19636020·J Clin Oncol·2009
8-other
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.
PMID 19620488·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1356327670
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile